Ibuprofène et paracétamol, promouvoir le bon usage

Ibuprofen and paracetamol are certainly the best known and most widely used drugs. They are easily accessible to the entire population on prescription, advice or self-medication. The pharmacy team is responsible for their proper use.

Detalles Bibliográficos
Autor principal: Malbos, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486287/
https://www.ncbi.nlm.nih.gov/pubmed/32952281
http://dx.doi.org/10.1016/j.actpha.2020.06.010
_version_ 1783581307807203328
author Malbos, Damien
author_facet Malbos, Damien
author_sort Malbos, Damien
collection PubMed
description Ibuprofen and paracetamol are certainly the best known and most widely used drugs. They are easily accessible to the entire population on prescription, advice or self-medication. The pharmacy team is responsible for their proper use.
format Online
Article
Text
id pubmed-7486287
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-74862872020-09-14 Ibuprofène et paracétamol, promouvoir le bon usage Malbos, Damien Actual Pharm Article Ibuprofen and paracetamol are certainly the best known and most widely used drugs. They are easily accessible to the entire population on prescription, advice or self-medication. The pharmacy team is responsible for their proper use. Elsevier Masson SAS. 2020-09 2020-09-12 /pmc/articles/PMC7486287/ /pubmed/32952281 http://dx.doi.org/10.1016/j.actpha.2020.06.010 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Malbos, Damien
Ibuprofène et paracétamol, promouvoir le bon usage
title Ibuprofène et paracétamol, promouvoir le bon usage
title_full Ibuprofène et paracétamol, promouvoir le bon usage
title_fullStr Ibuprofène et paracétamol, promouvoir le bon usage
title_full_unstemmed Ibuprofène et paracétamol, promouvoir le bon usage
title_short Ibuprofène et paracétamol, promouvoir le bon usage
title_sort ibuprofène et paracétamol, promouvoir le bon usage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486287/
https://www.ncbi.nlm.nih.gov/pubmed/32952281
http://dx.doi.org/10.1016/j.actpha.2020.06.010
work_keys_str_mv AT malbosdamien ibuprofeneetparacetamolpromouvoirlebonusage

Ejemplares similares